CN102662067A - 一种无氰化测定血红蛋白浓度及白细胞分群计数的溶血素 - Google Patents
一种无氰化测定血红蛋白浓度及白细胞分群计数的溶血素 Download PDFInfo
- Publication number
- CN102662067A CN102662067A CN2012101621448A CN201210162144A CN102662067A CN 102662067 A CN102662067 A CN 102662067A CN 2012101621448 A CN2012101621448 A CN 2012101621448A CN 201210162144 A CN201210162144 A CN 201210162144A CN 102662067 A CN102662067 A CN 102662067A
- Authority
- CN
- China
- Prior art keywords
- hemolysin
- concentration
- leucocyte
- counting
- hive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010006464 Hemolysin Proteins Proteins 0.000 title claims abstract description 40
- 239000003228 hemolysin Substances 0.000 title claims abstract description 40
- 210000000265 leukocyte Anatomy 0.000 title abstract description 22
- 108010054147 Hemoglobins Proteins 0.000 title abstract description 16
- 102000001554 Hemoglobins Human genes 0.000 title abstract description 16
- 238000004820 blood count Methods 0.000 title abstract description 11
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 22
- 239000003093 cationic surfactant Substances 0.000 claims abstract description 14
- 239000003446 ligand Substances 0.000 claims abstract description 14
- 210000003743 erythrocyte Anatomy 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims abstract description 8
- XNRNJIIJLOFJEK-UHFFFAOYSA-N sodium;1-oxidopyridine-2-thione Chemical compound [Na+].[O-]N1C=CC=CC1=S XNRNJIIJLOFJEK-UHFFFAOYSA-N 0.000 claims abstract description 7
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 150000003242 quaternary ammonium salts Chemical group 0.000 claims description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 7
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000000304 alkynyl group Chemical group 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 3
- 235000015165 citric acid Nutrition 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- 235000011167 hydrochloric acid Nutrition 0.000 claims description 3
- 235000006408 oxalic acid Nutrition 0.000 claims description 3
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 239000001384 succinic acid Substances 0.000 claims description 2
- 125000002769 thiazolinyl group Chemical group 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 abstract description 8
- 210000001616 monocyte Anatomy 0.000 abstract description 5
- 239000003945 anionic surfactant Substances 0.000 abstract description 4
- 231100000419 toxicity Toxicity 0.000 abstract description 4
- 230000001988 toxicity Effects 0.000 abstract description 4
- 230000000711 cancerogenic effect Effects 0.000 abstract description 3
- 231100000315 carcinogenic Toxicity 0.000 abstract description 3
- 210000003714 granulocyte Anatomy 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 abstract description 3
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- 239000002535 acidifier Substances 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 18
- 239000008280 blood Substances 0.000 description 18
- 239000000523 sample Substances 0.000 description 17
- 238000000034 method Methods 0.000 description 13
- 239000003085 diluting agent Substances 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 6
- -1 H-azanol Chemical compound 0.000 description 5
- 238000000862 absorption spectrum Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 230000008021 deposition Effects 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000003979 eosinophil Anatomy 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 210000004493 neutrocyte Anatomy 0.000 description 2
- JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 2
- UDATXMIGEVPXTR-UHFFFAOYSA-N 1,2,4-triazolidine-3,5-dione Chemical compound O=C1NNC(=O)N1 UDATXMIGEVPXTR-UHFFFAOYSA-N 0.000 description 1
- QUKGLNCXGVWCJX-UHFFFAOYSA-N 1,3,4-thiadiazol-2-amine Chemical compound NC1=NN=CS1 QUKGLNCXGVWCJX-UHFFFAOYSA-N 0.000 description 1
- ZMCHBSMFKQYNKA-UHFFFAOYSA-N 2-aminobenzenesulfonic acid Chemical compound NC1=CC=CC=C1S(O)(=O)=O ZMCHBSMFKQYNKA-UHFFFAOYSA-N 0.000 description 1
- KKMZQOIASVGJQE-UHFFFAOYSA-N 3-thiophen-2-ylprop-2-enoic acid Chemical compound OC(=O)C=CC1=CC=CS1 KKMZQOIASVGJQE-UHFFFAOYSA-N 0.000 description 1
- NKOPQOSBROLOFP-UHFFFAOYSA-N 6-methyl-3-sulfanylidene-2h-1,2,4-triazin-5-one Chemical compound CC1=NNC(=S)NC1=O NKOPQOSBROLOFP-UHFFFAOYSA-N 0.000 description 1
- 108010044267 Abnormal Hemoglobins Proteins 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 229930185605 Bisphenol Natural products 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 208000002903 Thalassemia Diseases 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- ISWQCIVKKSOKNN-UHFFFAOYSA-L Tiron Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ISWQCIVKKSOKNN-UHFFFAOYSA-L 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- RRUDCFGSUDOHDG-UHFFFAOYSA-N acetohydroxamic acid Chemical compound CC(O)=NO RRUDCFGSUDOHDG-UHFFFAOYSA-N 0.000 description 1
- 229960001171 acetohydroxamic acid Drugs 0.000 description 1
- 210000002659 acromion Anatomy 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000010165 autogamy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000007333 cyanation reaction Methods 0.000 description 1
- 108010071981 cyanhemoglobin Proteins 0.000 description 1
- 108700042971 cyanomethemoglobin Proteins 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 239000003219 hemolytic agent Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- VFQXVTODMYMSMJ-UHFFFAOYSA-N isonicotinamide Chemical compound NC(=O)C1=CC=NC=C1 VFQXVTODMYMSMJ-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- UYDLBVPAAFVANX-UHFFFAOYSA-N octylphenoxy polyethoxyethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCO)C=C1 UYDLBVPAAFVANX-UHFFFAOYSA-N 0.000 description 1
- 239000013110 organic ligand Substances 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 150000003217 pyrazoles Chemical class 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- LOAUVZALPPNFOQ-UHFFFAOYSA-N quinaldic acid Chemical compound C1=CC=CC2=NC(C(=O)O)=CC=C21 LOAUVZALPPNFOQ-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
1 | 2 | 3 | 4 | 5 | 平均值 | |
HGB | 0.9965 | 0.9981 | 0.9972 | 0.9977 | 0.9980 | 0.9975 |
WBC | Lym% | Gran% | HGB | |
r | 0.9921 | 0.9549 | 0.9542 | 0.9961 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210162144.8A CN102662067B (zh) | 2012-05-20 | 2012-05-20 | 一种无氰化测定血红蛋白浓度及白细胞分群计数的溶血素 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210162144.8A CN102662067B (zh) | 2012-05-20 | 2012-05-20 | 一种无氰化测定血红蛋白浓度及白细胞分群计数的溶血素 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102662067A true CN102662067A (zh) | 2012-09-12 |
CN102662067B CN102662067B (zh) | 2014-07-02 |
Family
ID=46771598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210162144.8A Active CN102662067B (zh) | 2012-05-20 | 2012-05-20 | 一种无氰化测定血红蛋白浓度及白细胞分群计数的溶血素 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102662067B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103698501A (zh) * | 2013-12-23 | 2014-04-02 | 深圳市开立科技有限公司 | 一种无氰化物溶血剂 |
CN104634953A (zh) * | 2015-02-28 | 2015-05-20 | 韩冰 | 一种环保无毒型溶血剂 |
CN106932350A (zh) * | 2017-03-22 | 2017-07-07 | 安徽民泰医药科技有限公司 | 血细胞分析用溶血剂 |
CN107101933A (zh) * | 2017-07-10 | 2017-08-29 | 郑州金域临床检验中心(普通合伙) | 一种血液分析组合物及其应用 |
CN108169105A (zh) * | 2017-11-07 | 2018-06-15 | 山东卓越生物技术股份有限公司 | 应用于血细胞分析仪的白细胞分类处理方法 |
CN108872225A (zh) * | 2018-07-17 | 2018-11-23 | 浙江亚培生物技术有限公司 | 一种检测动物血球的检测试剂及检测方法 |
CN110132899A (zh) * | 2018-02-02 | 2019-08-16 | 深圳市帝迈生物技术有限公司 | 一种用于白细胞分类的溶血剂 |
CN110954489A (zh) * | 2019-11-15 | 2020-04-03 | 中山市创艺生化工程有限公司 | 一种无氰溶血剂及其应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4617275A (en) * | 1983-09-29 | 1986-10-14 | Toa Medical Electronics Co., Ltd. | Reagent for blood analysis |
US5763280A (en) * | 1997-01-21 | 1998-06-09 | Coulter International Corp. | Cyanide-free lytic reagent composition and method for hemoglobin and cell analysis |
CN1215168A (zh) * | 1997-10-17 | 1999-04-28 | 库特国际公司 | 用于血红蛋白测量和白细胞区分的不含氰化物的试剂及其方法 |
WO2000049408A2 (en) * | 1999-02-18 | 2000-08-24 | Dade Behring Inc. | Method for providing a stabilized myoglobin biochemical reagent |
CN1294682A (zh) * | 1998-03-24 | 2001-05-09 | 库特国际公司 | 用于血红蛋白和细胞分析的组合物与方法 |
CN1277125C (zh) * | 2003-08-20 | 2006-09-27 | 深圳迈瑞生物医疗电子股份有限公司 | 无氰化物溶血素 |
CN101163972A (zh) * | 2005-05-04 | 2008-04-16 | 贝克曼考尔特公司 | 无氰化物的溶解剂组合物及其用于血红蛋白和白血球测定的方法 |
-
2012
- 2012-05-20 CN CN201210162144.8A patent/CN102662067B/zh active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4617275A (en) * | 1983-09-29 | 1986-10-14 | Toa Medical Electronics Co., Ltd. | Reagent for blood analysis |
US4656139A (en) * | 1983-09-29 | 1987-04-07 | Toa Medical Electronics Co., Ltd. | Method for preparing cells for blood analysis |
US5763280A (en) * | 1997-01-21 | 1998-06-09 | Coulter International Corp. | Cyanide-free lytic reagent composition and method for hemoglobin and cell analysis |
CN1244259A (zh) * | 1997-01-21 | 2000-02-09 | 库特国际公司 | 用于血红蛋白和细胞分析的无氰化物裂解试剂组合物与方法 |
CN1215168A (zh) * | 1997-10-17 | 1999-04-28 | 库特国际公司 | 用于血红蛋白测量和白细胞区分的不含氰化物的试剂及其方法 |
CN1130567C (zh) * | 1997-10-17 | 2003-12-10 | 库特国际公司 | 测量血红蛋白和区分白细胞的不含氰化物的试剂及方法 |
CN1294682A (zh) * | 1998-03-24 | 2001-05-09 | 库特国际公司 | 用于血红蛋白和细胞分析的组合物与方法 |
WO2000049408A2 (en) * | 1999-02-18 | 2000-08-24 | Dade Behring Inc. | Method for providing a stabilized myoglobin biochemical reagent |
CN1277125C (zh) * | 2003-08-20 | 2006-09-27 | 深圳迈瑞生物医疗电子股份有限公司 | 无氰化物溶血素 |
CN101163972A (zh) * | 2005-05-04 | 2008-04-16 | 贝克曼考尔特公司 | 无氰化物的溶解剂组合物及其用于血红蛋白和白血球测定的方法 |
Non-Patent Citations (3)
Title |
---|
杨胜科 等: "无氰化物测定血红蛋白的方法研究", 《分析科学学报》 * |
胡秋娈 等: "一种无氰化物测定血红蛋白的分光光度法", 《分析测试学报》 * |
黄博 等: "血红蛋白浓度的光学测量方法与装置", 《光学精密工程》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103698501A (zh) * | 2013-12-23 | 2014-04-02 | 深圳市开立科技有限公司 | 一种无氰化物溶血剂 |
CN104634953A (zh) * | 2015-02-28 | 2015-05-20 | 韩冰 | 一种环保无毒型溶血剂 |
CN106932350A (zh) * | 2017-03-22 | 2017-07-07 | 安徽民泰医药科技有限公司 | 血细胞分析用溶血剂 |
CN107101933A (zh) * | 2017-07-10 | 2017-08-29 | 郑州金域临床检验中心(普通合伙) | 一种血液分析组合物及其应用 |
CN108169105A (zh) * | 2017-11-07 | 2018-06-15 | 山东卓越生物技术股份有限公司 | 应用于血细胞分析仪的白细胞分类处理方法 |
CN108169105B (zh) * | 2017-11-07 | 2020-12-18 | 山东卓越生物技术股份有限公司 | 应用于血细胞分析仪的白细胞分类处理方法 |
CN110132899A (zh) * | 2018-02-02 | 2019-08-16 | 深圳市帝迈生物技术有限公司 | 一种用于白细胞分类的溶血剂 |
CN108872225A (zh) * | 2018-07-17 | 2018-11-23 | 浙江亚培生物技术有限公司 | 一种检测动物血球的检测试剂及检测方法 |
CN110954489A (zh) * | 2019-11-15 | 2020-04-03 | 中山市创艺生化工程有限公司 | 一种无氰溶血剂及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102662067B (zh) | 2014-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102662067B (zh) | 一种无氰化测定血红蛋白浓度及白细胞分群计数的溶血素 | |
CN101163972B (zh) | 无氰化物的溶解剂组合物及其用于血红蛋白和白血球测定的方法 | |
Rendal et al. | The effect of pH on the uptake and toxicity of the bivalent weak base chloroquine tested on Salix viminalis and Daphnia magna | |
CN103323582B (zh) | 一种白细胞分类溶血剂及其试剂盒 | |
Boyd et al. | Interpretation of pH, acidity, and alkalinity in aquaculture and fisheries | |
CN102226804B (zh) | 一种用于血液白细胞五分类计数的溶血剂及其用途 | |
CN103698501B (zh) | 一种无氰化物溶血剂 | |
Bernot et al. | Acute and chronic toxicity of imidazolium‐based ionic liquids on Daphnia magna | |
CA1117401A (en) | Multi-purpose blood diluent for use in electronic blood analysis instrumentation | |
DE69827636T2 (de) | Blutverdünnungsreagenz | |
JP5122967B2 (ja) | 血液サンプル中の異なる種類の血液細胞の同時計数のための溶解試薬 | |
JP2008032750A (ja) | ヘモグロビン及び細胞分析のためのシアン化物不含溶解試薬組成物及び方法 | |
CN1294682A (zh) | 用于血红蛋白和细胞分析的组合物与方法 | |
CN101451931B (zh) | 血液稀释液及其使用方法 | |
CN103575702B (zh) | 白细胞分类计数试剂和白细胞分类方法 | |
Urrechaga et al. | Analysis of reticulocyte parameters on the Sysmex XE 5000 and LH 750 analyzers in the diagnosis of inefficient erythropoiesis | |
CN104297134A (zh) | 一种溶血剂及其应用和白细胞分类计数方法 | |
CN101464453B (zh) | 一种溶血剂 | |
CN108872225A (zh) | 一种检测动物血球的检测试剂及检测方法 | |
CN110542640A (zh) | 一种五分类血细胞分析仪用白细胞分类试剂盒 | |
CN101329229A (zh) | 血细胞分析用无氰白细胞三分群环保型溶血素 | |
CN1277125C (zh) | 无氰化物溶血素 | |
Okediran et al. | Haemato-biochemical alterations as biomarkers of lead induced toxicity in male Wistar rats. | |
CN110160941A (zh) | 一种三分类血细胞分析仪用试剂 | |
Chang et al. | Inter-laboratory validation of the in-vivo flow cytometric micronucleus analysis method (MicroFlow®) in China |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 264003 Laishan Province, Yantai District, Bao Road, No., No. 10 Patentee after: Shandong excellence biotechnology Limited by Share Ltd Address before: 264003 Laishan Province, Yantai District, Bao Road, No., No. 10 Patentee before: Yantai Excellent Biotechnology Co., Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Cyanide-free hemolysin for determining hemoglobin concentration and carrying out white blood cell count by groups Effective date of registration: 20170921 Granted publication date: 20140702 Pledgee: Yantai financing Company Limited by Guarantee Pledgor: Shandong excellence biotechnology Limited by Share Ltd Registration number: 2017370000144 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200918 Granted publication date: 20140702 Pledgee: Yantai financing Company Limited by Guarantee Pledgor: B&E BIO-TECHNOLOGY Co.,Ltd. Registration number: 2017370000144 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A hemolysin for measuring hemoglobin concentration and leukocyte grouping count without cyanide Effective date of registration: 20211202 Granted publication date: 20140702 Pledgee: Rizhao Bank Co.,Ltd. Yantai Zhifu sub branch Pledgor: B&E BIO-TECHNOLOGY CO.,LTD. Registration number: Y2021980013711 |